ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.79
0.20%
US Tech 100
17,730.00
0.51%
S&P 500
5,227.68
0.26%
US Dollar vs CAD
1.36465
-0.23%
Bitcoin
62,481.16
-0.90%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Applied Therapeutics Inc (APLT)

  7. Applied Therapeutics Inc (APLT) News

APLT

Applied Therapeutics (APLT)

Applied Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:APLT
DateTimeSourceHeadlineSymbolCompany
05/09/20246:17AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APLTApplied Therapeutics Inc
05/09/20246:13AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APLTApplied Therapeutics Inc
05/09/20246:00AMGlobeNewswire Inc.Applied Therapeutics Reports First Quarter 2024 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
05/07/20246:00AMGlobeNewswire Inc.Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:APLTApplied Therapeutics Inc
04/15/20246:00AMGlobeNewswire Inc.Applied Therapeutics Appoints Dale Hooks as Chief Commercial OfficerNASDAQ:APLTApplied Therapeutics Inc
04/04/20246:00AMGlobeNewswire Inc.Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024NASDAQ:APLTApplied Therapeutics Inc
03/28/20243:30PMGlobeNewswire Inc.Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic GalactosemiaNASDAQ:APLTApplied Therapeutics Inc
03/11/20247:17AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APLTApplied Therapeutics Inc
03/06/20246:19AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:APLTApplied Therapeutics Inc
03/06/20246:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APLTApplied Therapeutics Inc
03/06/20246:00AMGlobeNewswire Inc.Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
03/05/20244:42PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:APLTApplied Therapeutics Inc
02/29/20243:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APLTApplied Therapeutics Inc
02/28/20247:05AMGlobeNewswire Inc.Applied Therapeutics Announces $100 Million Private PlacementNASDAQ:APLTApplied Therapeutics Inc
02/28/20247:00AMGlobeNewswire Inc.Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic GalactosemiaNASDAQ:APLTApplied Therapeutics Inc
02/22/20241:26PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APLTApplied Therapeutics Inc
02/15/20246:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APLTApplied Therapeutics Inc
02/15/20246:00AMGlobeNewswire Inc.Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD) DeficiencyNASDAQ:APLTApplied Therapeutics Inc
02/14/20248:20PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APLTApplied Therapeutics Inc
02/13/20243:34PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:APLTApplied Therapeutics Inc
01/04/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APLTApplied Therapeutics Inc
01/04/20243:05PMGlobeNewswire Inc.Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic CardiomyopathyNASDAQ:APLTApplied Therapeutics Inc
01/03/202410:20AMDow Jones NewsApplied Therapeutics Shares Hit 52-Week High on Govorestat FilingsNASDAQ:APLTApplied Therapeutics Inc
01/03/20248:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APLTApplied Therapeutics Inc
01/03/20246:00AMGlobeNewswire Inc.Applied Therapeutics Announces MAA Validation and NDA Submission of Govorestat (AT-007) for Treatment of Classic GalactosemiaNASDAQ:APLTApplied Therapeutics Inc
12/29/20233:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APLTApplied Therapeutics Inc
12/22/20237:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APLTApplied Therapeutics Inc
12/22/20237:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APLTApplied Therapeutics Inc
12/22/20237:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APLTApplied Therapeutics Inc
12/05/20236:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APLTApplied Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:APLT

Your Recent History

USOTC
TXTM
ProText Mobility (PK)
USOTC
EMGE
Emergent Health (PK)
USOTC
SONG
Music Licensing (PK)
NASDAQ
RNAZ
TransCode Therapeutics
USOTC
IQST
iQSTEL (QX)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
GNCP
GNCC Capital (CE)
USOTC
CLNV
Clean Vision (QB)
USOTC
YCRM
Yuenglings Ice Cream (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
RDAR
Raadr (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
INQD
Indoor Harvest (PK)
USOTC
CNNA
Cann American (CE)
USOTC
RONN
Ronn Motor (PK)
USOTC
TKMO
Tekumo (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved